The clinical evidence for semaglutides weight loss effects is among the strongest in the history of obesity pharmacology but it requires careful context to interpret accurately
The lid is made from safe, food-grade SAN plastic, ensuring durability and protection without harmful materials
This data lets your clinician optimize your starting dose and escalation schedule upfront, avoiding months of trial-and-error and accelerating your path to therapeutic effect
However large scale, robust studies in humans are needed, while it is unclear if such drugs dampen reward signalling generally in the brain raising concerns around their use in people with depression
For adults, the common TGA pattern is this: these medicines may be used for chronic weight management in people with a BMI of 30 or more , or a BMI of 27 or more with at least one weight-related comorbidity such as hypertension, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, prediabetes or type 2 diabetes, depending on the product
